Biotricity, Inc. (BTCY)
OTCMKTS
· Delayed Price · Currency is USD
0.292
+0.011 (3.98%)
Dec 18, 2024, 3:00 PM EST
Biotricity Revenue
Biotricity had revenue of $3.27M in the quarter ending September 30, 2024, with 12.99% growth. This brings the company's revenue in the last twelve months to $12.62M, up 13.55% year-over-year. In the fiscal year ending March 31, 2024, Biotricity had annual revenue of $12.06M with 25.15% growth.
Revenue (ttm)
12.62M
Revenue Growth
+13.55%
P/S Ratio
0.32
Revenue / Employee
229.45K
Employees
55
Market Cap
7.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 12.06M | 2.42M | 25.15% |
| Mar 31, 2023 | 9.64M | 1.99M | 26.00% |
| Mar 31, 2022 | 7.65M | 4.27M | 126.02% |
| Mar 31, 2021 | 3.38M | 1.97M | 138.75% |
| Mar 31, 2020 | 1.42M | 1.02M | 256.03% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.66B |
| Ryman Healthcare Limited | 458.44M |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.53M |
| Medexus Pharmaceuticals Inc. | 104.76M |
Biotricity News
- 15 days ago - Biotricity achieves positive free cash flow - Seeking Alpha
- 15 days ago - Biotricity Achieves Positive Free Cash Flow Milestone - PRNewsWire
- 4 weeks ago - Biotricity, Inc. (BTCY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Biotricity GAAP EPS of -$0.07, revenue of $3.3M - Seeking Alpha
- 4 weeks ago - Biotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025 - GlobeNewsWire
- 5 weeks ago - Biotricity to Host Second Quarter Fiscal Year 2025 Financial Results and Business Update Call on November 15th - GlobeNewsWire
- 2 months ago - Biotricity reaches EBITDA positive on go-forward cash basis - Seeking Alpha
- 2 months ago - Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins - Accesswire